Central Nervous System Embryonal Tumor — Trials

Central Nervous System Embryonal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

240 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 72
Recruiting: 33
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03904862	Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery	terminated	Phase 1 / Phase 2	21	Pediatric Brain Tumor ConsortiumNETWORK	1	Oct 30, 2025	clinicaltrials
NCT01483820	Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma	terminated	Phase 1 / Phase 2	8	Giselle ShollerOTHER	1	Aug 6, 2024	clinicaltrials